The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
about
Surgical pathology of early stage non-small cell lung carcinomaCharge-reversal nanoparticles: novel targeted drug delivery carriersComparison of detection methods and follow-up study on the tyrosine kinase inhibitors therapy in non-small cell lung cancer patients with ROS1 fusion rearrangement.China Experts Consensus on the Diagnosis and Treatment of Advanced Stage Primary Lung Cancer (2016 Version)Personalized treatment of advanced non-small-cell lung cancer in routine clinical practiceHistopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumorsPrognostic value of immunohistochemical markers in malignant thymic epithelial tumorsKeratinization of Lung Squamous Cell Carcinoma Is Associated with Poor Clinical OutcomePulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening methodUtility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis.Epidemiological features of lung giant cell carcinoma and therapy for patients with EGFR mutations based on case reports and the surveillance, epidemiology, and end results (SEER) database.The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung CancerDynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma.Different dissecting orders of the pulmonary bronchus and vessels during right upper lobectomy are associated with surgical feasibility and postoperative recovery for lung cancer patients.FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.Baicalein Induces Caspase-dependent Apoptosis Associated with the Generation of ROS and the Activation of AMPK in Human Lung Carcinoma A549 Cells.Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic AnalysisDetection of rearrangement of anaplastic lymphoma kinase (ALK) and mutation of epidermal growth factor receptor (EGFR) in primary pulmonary lymphoepithelioma-like carcinoma.Pulmonary lymphoepithelioma-like carcinoma: a Surveillance, Epidemiology, and End Results database analysisDetection of lung adenocarcinoma with ROS1 rearrangement by IHC, FISH, and RT-PCR and analysis of its clinicopathologic featuresThe equivalent efficacy of multiple operations for multiple primary lung cancer and a single operation for single primary lung cancer.Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis.Right upper lobectomy performed as dividing posterior ascending artery-bronchus-pulmonary vessels is alternative to primary indolent scar carcinomasLow level of 5-Hydroxymethylcytosine predicts poor prognosis in non-small cell lung cancerDetection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancerFrequencies of ALK rearrangements in lung adenocarcinoma subtypes: a study of 2299 Chinese cases.Pulmonary sclerosing pneumocytoma mimicking lung cancer: Case report and review of the literatureTranscription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.Pure ground-glass opacity on chest computed tomography: predictive factors for invasive adenocarcinomaMethod for discriminating synchronous multiple lung cancers of the same histological type: miRNA expression analysis.Analysis of mutational and clinicopathologic characteristics of lung adenocarcinoma with clear cell componentPrognostic value of MMP9 activity level in resected stage I B lung adenocarcinoma.Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule.The effectiveness of mediastinal lymph node evaluation in a patient with ground glass opacity tumor.Genomic heterogeneity of multiple synchronous lung cancer.Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma.EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS.Single-port video-assisted thoracic surgery in the treatment of non-small cell lung cancer: a propensity-matched comparative analysis.A retrospective analysis of the clinicopathological and molecular characteristics of pulmonary blastoma.FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
P2860
Q26739713-A6FB3438-61DF-498B-96FE-BB0ABBC0FE84Q26740583-74D5DBCB-3A2C-4B90-97DE-3549D8C04828Q27311389-8951E50F-1F38-4C25-B043-C19E761837AAQ28073920-033DCC9F-57D0-4730-A2D1-5770F0B9DE82Q28075800-7B5E5FA5-B405-4437-AD11-3E6962FD16D4Q28077504-A2B1A0E4-4F28-46CD-AFA9-BCFE141B5413Q28279154-A3A54D57-FBC4-402E-A3BD-69E7F87F89BCQ33567377-8C50869C-A595-4030-A650-B68620A81F7CQ33587163-1ADEED0A-3971-4B20-8C87-A124C4B3B3E4Q33607511-E631794A-37D5-4B45-B9CA-4229D7B5BFF6Q33648864-38DBA012-334F-43D1-A4F6-D095EAB2AA46Q33747929-D2EEC95F-13DB-4DF1-9945-0191A8D7B115Q33762059-EF211187-B6AA-437C-959B-ABAE859CB36EQ33846146-36FD1F38-6227-4CCC-9570-16E39485FA28Q33913015-8F4CE297-3292-4001-B177-8D0BA512FE88Q35955377-8BC805F5-FB16-4F66-B9E9-5D28DEA36EDEQ36128151-1F775888-9D1B-44BF-B471-739FEB314322Q36138364-CCFE23C2-1FBC-497A-99A4-99B9C09BBC86Q36437549-611CC06F-BE69-49DE-A47A-474FDFF48133Q36444609-5A9379B8-D431-4CBA-BBF2-FB1640D0B9AAQ36829754-B91EB61F-2C84-444B-AAAD-100D7F22799AQ36874762-8D32578E-236B-420C-841B-4B5B5DE89F4CQ36948872-CBAC470F-5984-4EC1-B7FA-26B31A99A8F8Q36954584-10529BCC-BABD-4C5A-B3A9-917509ECD0D5Q37018090-64ACAE45-F982-41FA-9B7E-931D9FB8D444Q37042926-223F2D48-01CD-4D1E-8058-F98A3738FC21Q37060424-8097A6B6-EA91-4064-8A4D-BA0F2E5E3C39Q37116260-50243E27-4848-43AE-B3CD-53113F67D819Q37121389-D7A0BB5B-6511-4650-A506-7A79BD8D7C50Q37165200-DCF33FB2-76C1-4FC5-BA7B-81166309A9A1Q37269374-919EA2F1-9D0F-43E3-8D7C-DBF7FDDF2744Q37321106-A6DAB40A-77CD-4594-87E2-4F2BDD40C89DQ37329374-2B6EBFB5-6001-440B-9C66-F92E71FA4B4CQ37329520-EF782213-5AB8-4353-9ED9-32178A5FBB0CQ37363816-E14268FA-209D-4EA4-B4A1-62D18BAA8988Q37376521-FEB8285A-5415-420A-B10C-74315D2E1EC1Q37397803-B3FE87EA-8813-4ED9-98BB-92FF36FB89C2Q37411239-37CE35C1-5650-4261-BABF-8CB59D4F494FQ37413101-CCC5AD21-CC33-4EBD-A4FF-3953E0C25035Q37462489-36F8EA0A-C8C5-443D-96F6-57246BE74955
P2860
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
The 2015 World Health Organiza ...... Since the 2004 Classification.
@en
The 2015 World Health Organiza ...... Since the 2004 Classification.
@nl
type
label
The 2015 World Health Organiza ...... Since the 2004 Classification.
@en
The 2015 World Health Organiza ...... Since the 2004 Classification.
@nl
prefLabel
The 2015 World Health Organiza ...... Since the 2004 Classification.
@en
The 2015 World Health Organiza ...... Since the 2004 Classification.
@nl
P2093
P50
P1476
The 2015 World Health Organiza ...... Since the 2004 Classification.
@en
P2093
Andrew G Nicholson
Douglas B Flieder
Edwina Duhig
Fred R Hirsch
Giuseppe Pelosi
John H M Austin
Keith M Kerr
Kim Geisinger
Lucian R Chirieac
Mary Beth Beasley
P304
P356
10.1097/JTO.0000000000000630
P577
2015-09-01T00:00:00Z